A detailed history of Jpmorgan Chase & CO transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 48,493 shares of PBYI stock, worth $131,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,493
Previous 17,994 169.5%
Holding current value
$131,416
Previous $58,000 112.07%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$2.25 - $4.03 $68,622 - $122,910
30,499 Added 169.5%
48,493 $123,000
Q2 2024

Aug 12, 2024

SELL
$2.92 - $5.83 $35,647 - $71,172
-12,208 Reduced 40.42%
17,994 $58,000
Q1 2024

May 10, 2024

BUY
$4.29 - $7.4 $12,904 - $22,259
3,008 Added 11.06%
30,202 $160,000
Q4 2023

Feb 12, 2024

BUY
$2.23 - $4.49 $60,511 - $121,836
27,135 Added 45991.53%
27,194 $117,000
Q3 2023

Nov 14, 2023

SELL
$2.63 - $4.09 $2,745 - $4,269
-1,044 Reduced 94.65%
59 $0
Q4 2022

Feb 13, 2023

SELL
$2.12 - $5.08 $3,701 - $8,869
-1,746 Reduced 61.28%
1,103 $5,000
Q3 2022

Nov 14, 2022

BUY
$2.27 - $3.84 $1,400 - $2,369
617 Added 27.64%
2,849 $7,000
Q2 2022

Aug 11, 2022

SELL
$1.64 - $3.3 $230,664 - $464,141
-140,649 Reduced 98.44%
2,232 $6,000
Q1 2022

May 11, 2022

SELL
$2.13 - $3.24 $1,312 - $1,995
-616 Reduced 0.43%
142,881 $412,000
Q4 2021

Feb 10, 2022

SELL
$2.85 - $6.58 $15,512 - $35,814
-5,443 Reduced 3.65%
143,497 $437,000
Q3 2021

Nov 12, 2021

BUY
$6.63 - $9.39 $987,472 - $1.4 Million
148,940 New
148,940 $1.04 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $123M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.